Plasma microRNA-21 is associated with tumor burden in cutaneous melanoma.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Investigative Dermatology

• Publication date

  2013-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/jid.2012.477PMID 23303460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The status of microRNA-21 expression and its clinical significance in human cutaneous malignant melanoma.

  2012cited by this paper
• microRNA‐21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells

  2012cited by this paper
• Serum microRNAs as biomarkers for recurrence in melanoma

  2012cited by this paper
• Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.

  2011cited by this paper
• Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

  2011cited by this paper
• miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions

  2011cited by this paper
• Final version of 2009 AJCC melanoma staging and classification.

  2009cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• miRBase: tools for microRNA genomics

  2007cited by this paper
• Melanoma risk in congenital melanocytic naevi: a systematic review

  2006cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• microRNAs exhibit high frequency genomic alterations in human cancer.

  2006cited by this paper
• Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

  2002cited by this paper

• Targeting the microbiota-miRNA-protease axis: A new therapeutic avenue in melanoma.

  2026cites this paper
• Circulating MicroRNAs: functional biomarkers for melanoma prognosis and treatment

  2025cites this paper
• Determination of Common microRNA Biomarker Candidates in Stage IV Melanoma Patients and a Human Melanoma Cell Line: A Potential Anti-Melanoma Agent Screening Model

  2023cites this paper
• Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis

  2023cites this paper
• Preoperative Plasma miRNA Levels Predict Prognosis in Early-stage Malignant Melanoma

  2023cites this paper
• Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer

  2022influential citation
• Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives

  2022cites this paper
• Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine

  2021cites this paper
• Predictive Biomarkers of Melanoma

  2021cites this paper
• MicroRNA-21-Enriched Exosomes as Epigenetic Regulators in Melanomagenesis and Melanoma Progression: The Impact of Western Lifestyle Factors

  2020cites this paper
• Advances in Natural or Synthetic Nanoparticles for Metastatic Melanoma Therapy and Diagnosis

  2020cites this paper
• Importance of microRNAs in Skin Oncogenesis and Their Suitability as Agents and Targets for Topical Therapy

  2020cites this paper
• Role of miRNAs in Melanoma Metastasis

  2019cites this paper
• Circulating miRNA expression analysis reveals new potential biomarkers for human cutaneous melanoma staging

  2019cites this paper
• Circulating cell‐free microRNAs in cutaneous melanoma staging and recurrence or survival prognosis

  2019influential citation
• Liquid Biopsy: From Basic Research to Clinical Practice.

  2018cites this paper
• Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine

  2018cites this paper
• Alterations in patient plasma microRNA expression profiles following resection of metastatic melanoma

  2018cites this paper
• Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients

  2018cites this paper
• The Circulating Transcriptome as a Source of Biomarkers for Melanoma

  2018cites this paper
• Interplay between small and long non‐coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces

  2018cites this paper
• Emerging Biomarkers in Cutaneous Melanoma

  2018cites this paper
• Circulating cell-free microRNAs as clinical cancer biomarkers

  2017cites this paper
• Circulating cell-free microRNAs as clinical cancer biomarkers.

  2017cites this paper
• Plasma microRNAs – novel markers for the detection of colonic polyps and their progression to colorectal cancer

  2017cites this paper
• Quantification of microRNA-21 and microRNA-125b in melanoma tissue

  2017cites this paper
• MicroRNA in skin diseases

  2017cites this paper
• Cell-free plasma markers of breast cancer in young women and women at high risk

  2016influential citation
• MicroRNA profiling of patient plasma for clinical trials using bioinformatics and biostatistical approaches

  2016cites this paper
• Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients

  2016cites this paper
• microRNA-10b is a prognostic biomarker for melanoma

  2016cites this paper
• miRNAs in melanoma: a defined role in tumor progression and metastasis

  2016cites this paper
• miRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential.

  2016cites this paper
• Gr upSM Circulating MicroRNAs in Cutaneous Melanoma Diagnosis and Prognosis

  2016cites this paper
• Circulating MicroRNAs in Cutaneous Melanoma Diagnosis and Prognosis

  2016cites this paper
• MicroRNA-21 expression and its pathogenetic significance in cutaneous melanoma

  2016cites this paper
• Invited Review MicroRNAs and Photocarcinogenesis

  2015cites this paper
• MicroRNAs in Skin Diseases

  2015cites this paper
• Circulating microRNAs as Candidate Biomarkers for the Surveillance of Melanoma Patients

  2015cites this paper
• An updated review of mechanotransduction in skin disorders: transcriptional regulators, ion channels, and microRNAs

  2015cites this paper
• MiR-21: an environmental driver of malignant melanoma?

  2015cites this paper
• Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer?

  2015cites this paper
• MicroRNAs and Photocarcinogenesis

  2015cites this paper
• MicroRNAs in cancer: lessons from melanoma.

  2014cites this paper
• MicroRNA‐mediated regulation of melanoma

  2014cites this paper
• Analysis of melanoma‐related microRNAs expression during the spontaneous regression of cutaneous melanomas in MeLiM pigs

  2014cites this paper
• Established and Emerging Biomarkers in Cutaneous Malignant Melanoma

  2014cites this paper